Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Martinez

Showing results (391-400 of 463) with videos related to

Pageof 47
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Journal of Neuro-Oncology|February 6, 2016
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trialCarmen Balana, Ramon De Las Penas, Juan Manuel Sepúlveda, et al.
Oncotarget|January 10, 2018
Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomasTareq A Juratli, Christian Thiede, Mara V A Koerner, et al.
Contemporary Clinical Trials|December 3, 2022
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trialEvelynne S Fulda, Carl J Fichtenbaum, Emma M Kileel, et al.
Brain Pathology (Zurich, Switzerland)|February 27, 2013
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastomaJoanna J Phillips, Derick Aranda, David W Ellison, et al.
BMC Medicine|August 10, 2023
Intensive community care services for children and young people in psychiatric crisis: an expert opinionEleanor Keiller, Saba Masood, Ben Hoi-Ching Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian CancerDavid E Gerber, Jeffrey R Infante, Michael S Gordon, et al.
The Lancet. Neurology|April 9, 2008
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisVivianna M Van Deerlin, James B Leverenz, Lynn M Bekris, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2023
Efficacy and safety of raltegravir plus lamivudine maintenance therapyBeatriz Borjabad, Alexy Inciarte, Ivan Chivite, et al.
Pageof 47

Showing results (391-400 of 463) with videos related to

Sort By:
Pageof 47
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial CancerLaura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Journal of Neuro-Oncology|February 6, 2016
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trialCarmen Balana, Ramon De Las Penas, Juan Manuel Sepúlveda, et al.
Oncotarget|January 10, 2018
Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomasTareq A Juratli, Christian Thiede, Mara V A Koerner, et al.
Contemporary Clinical Trials|December 3, 2022
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trialEvelynne S Fulda, Carl J Fichtenbaum, Emma M Kileel, et al.
Brain Pathology (Zurich, Switzerland)|February 27, 2013
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastomaJoanna J Phillips, Derick Aranda, David W Ellison, et al.
BMC Medicine|August 10, 2023
Intensive community care services for children and young people in psychiatric crisis: an expert opinionEleanor Keiller, Saba Masood, Ben Hoi-Ching Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian CancerDavid E Gerber, Jeffrey R Infante, Michael S Gordon, et al.
The Lancet. Neurology|April 9, 2008
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisVivianna M Van Deerlin, James B Leverenz, Lynn M Bekris, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2023
Efficacy and safety of raltegravir plus lamivudine maintenance therapyBeatriz Borjabad, Alexy Inciarte, Ivan Chivite, et al.
Pageof 47